We have previously shown that, assuming urea distribution volume (V) remains constant for 1 month, ionic dialysance (ID) allows the dialysis dose to be calculated without the need for blood sampling. The aim of this multicenter study was to verify whether the assumption of a constant V can be extended to 1 year. In clinically stable patients receiving thrice-weekly hemodialysis at 13 dialysis centers, V and K t /V were assessed during three dialysis sessions at baseline and 1 year later using ID as dialyzer urea clearance and the single-pool urea kinetic model. Baseline albumin, hemoglobin, and C reactive protein were prespecified covariates for predicting the change in V over time. Of the 52 enrolled patients, 40 (25 males; age 63.0713.5 years) completed the study. Baseline end-dialysis body weight (62.4713.7 kg) showed a non-significant 1% reduction during follow-up (À0.672.8 kg; P ¼ 0.175), whereas V significantly decreased from 29.076.8 to 27.476.0 l (À1.673.0 l or 4.5%; P ¼ 0.002). The reduction in V was greater when baseline albumin was lower (P ¼ 0.001) and baseline V was higher (P ¼ 0.005). The single-pool K t /V calculated using baseline V underestimated the actual value by 0.0770.16 (P ¼ 0.008). The slight underestimate of K t /V during follow-up suggests that annual V evaluations may be sufficient for dialysis dose quantification as the only risk is underestimating the actually delivered dialysis dose. However, the relationship between baseline albumin and the reduction in V over time may have nutritional value, and suggests more frequent V evaluations. Assessing the delivered dialysis dose (expressed as K t /V) is particularly relevant because of its relationship to morbidity and mortality.
We have previously shown that, assuming urea distribution volume (V) remains constant for 1 month, ionic dialysance (ID) allows the dialysis dose to be calculated without the need for blood sampling. The aim of this multicenter study was to verify whether the assumption of a constant V can be extended to 1 year. In clinically stable patients receiving thrice-weekly hemodialysis at 13 dialysis centers, V and K t /V were assessed during three dialysis sessions at baseline and 1 year later using ID as dialyzer urea clearance and the single-pool urea kinetic model. Baseline albumin, hemoglobin, and C reactive protein were prespecified covariates for predicting the change in V over time. Of the 52 enrolled patients, 40 (25 males; age 63.0713.5 years) completed the study. Baseline end-dialysis body weight (62.4713.7 kg) showed a non-significant 1% reduction during follow-up (À0.672.8 kg; P ¼ 0.175), whereas V significantly decreased from 29.076.8 to 27.476.0 l (À1.673.0 l or 4.5%; P ¼ 0.002). The reduction in V was greater when baseline albumin was lower (P ¼ 0.001) and baseline V was higher (P ¼ 0.005). The single-pool K t /V calculated using baseline V underestimated the actual value by 0.0770.16 (P ¼ 0.008). The slight underestimate of K t /V during follow-up suggests that annual V evaluations may be sufficient for dialysis dose quantification as the only risk is underestimating the actually delivered dialysis dose. However, the relationship between baseline albumin and the reduction in V over time may have nutritional value, and suggests more frequent V evaluations. Assessing the delivered dialysis dose (expressed as K t /V) is particularly relevant because of its relationship to morbidity and mortality. [1] [2] [3] [4] K t /V is usually determined by means of the single-pool, variable-volume urea kinetic model, which requires the taking of blood samples to determine urea concentrations at the start and end of each dialysis session. 5 As urea transfer from one body compartment to another is not instantaneous, and in order to avoid a significant overestimate of K t /V, the post-dialysis blood sample used for urea analysis is usually drawn 30 min after the end of the session (eqK t /V), when post-dialysis urea rebound is exhausted. 6 The alternative methods proposed by Smye et al. 7 and Daugirdas and Schneditz 8 obviate the problem of delayed post-dialysis blood sampling, but they also requires two or three blood samples. The result is that the delivered dialysis dose is quantified infrequently, and current international National Kidney Foundation Kidney Disease Outcomes Quality Initiative and European Best Practice Guidelines 9,10 recommend checking it at monthly intervals (a pragmatic rather than ideal recommendation).
On the other hand, a number of factors can lead to a lower than prescribed delivered dialysis dose, 11, 12 and some data suggest that there may be considerable variations in dose delivery between one session and another. 13, 14 Consequently, more frequent measurements may be desirable. When using the single-pool, variable volume urea kinetic model, the calculation of K t /V is based on solution for urea distribution volume (V) at the end of dialysis session. Once an average mean V value has been established for an individual patient, the delivered K t /V could be monitored at every dialysis session by determining dialyzer urea clearance (K) and treatment time (Td), because it seems reasonable to assume that V remains constant for prolonged periods of time in stable patients and only needs to be corrected for the difference in final body weight between one dialysis session and another.
The availability of online measurements of ionic dialysance (ID) may offer a step towards monitoring dialysis at each session. 15, 16 It has been shown that instantaneous effective ID can be measured without the need for any blood or dialysate sampling simply by using two conductivity probes placed at the dialyzer inlet and outlet. 17, 18 This allows repeated measurements of ID that can be used to obtain the mean value for the dialysis session as a whole.
In a previous study, 19 we showed that, once V has been determined, the use of ID makes it possible to calculate K t /V at each dialysis session without the need for blood sampling for at least 1 month.
This prospective multicenter study was planned in order to determine whether the assumption of a constant V in stable hemodialysis patients can be extended to such a long period as 1 year, and the extent of the bias of the K t /V calculations considering V as constant.
RESULTS General
Forty of the 52 patients recruited in the 13 Italian dialysis centers completed the planned 1-year follow-up: the 12 patients (23%) who dropped out earlier did so because of renal transplantation (one patient), transfer to another center (one), transfer to a dialytic run without the Integra machine and the Diascan module (one), vascular access thrombosis (one), leg amputation (one), myocardial infarction (one), the placement of a single-lumen central venous catheter (one), sepsis (one), hepatic coma (one), missing data concerning key relevant variables (one), and consent withdrawal (two).
The baseline characteristics of the 40 evaluated patients (25 males, 63%) are shown in Table 1 . They had a mean age of 63 years, a median dialysis vintage of 3.8 years, a mean dialysis time of 232 min per session and a mean end-dialysis body weight of 62.4 kg. Both types of dialysis membrane (cellulose, 22 patients; synthetic, 18) were used with a median dialysis surface area of 1.6 m 2 throughout the study. The mean blood flow rate was 318 ml/min and the dialysate flow rate was 500 ml/min. Thirty-four patients (85%) were dialyzed using a distal native fistula and six (15%) using a proximal native fistula.
Changes after 1 year
The within-patient variability in eq V and non-eq V, estimated by standard deviation, was 2.2971.44 and 2.2772.20 l at baseline, and 2.2271.57 and 2.0971.97 l after 1 year, with a mean difference of 0.0771.61 and 0.1973.00 l (P ¼ 0.784 and 0.697). The overall within-patient variability was therefore relevant, being 2.2671.50 and 2.1872.07 l (for eq V and non-eq V, respectively) over the entire follow-up.
The dialytic parameters and laboratory values at baseline and after 1 year are shown in Table 2 . As expected in the study protocol, blood flow rate, dialysis duration, and equilibrated and non-equilibrated K t /V remained constant during the follow-up; on the contrary, end-dialysis body weight, mean ID, and urea distribution volume decreased. Although the mean reduction in end-dialysis body weight at the end of the follow-up was only 0.672.8 kg and not significant (P ¼ 0.175), eq V calculated by means of the equilibrated post-dialysis sample (C t30 0 ) decreased by 1.9272.91 l (Po0.001). When the reduction in eq V was adjusted for the reduction in end-dialysis body weight, it was 1.3173.67 l and the difference from baseline remained significant (P ¼ 0.03).
The reduction in urea distribution volume after 1 year varied widely, as can be seen by the high standard deviations around the mean values of 2.91 for eq V and 2.99 l for non-eq V.
There was a direct and significant relationship between the decreases in V and ID using both eq V and non-eq V values. The adjusted R 2 values of the two linear models were, respectively, 0.09 (P ¼ 0.029) and 0.13 (P ¼ 0.013).
Accordingly, at the end of the follow-up, the eqK t /V value estimated using baseline V values was significantly lower than the up-dated value: the mean difference was À0.0770.11, an underestimate of 5.3% (Po0.001). Likewise, the V calculated using the post-dialysis non-equilibrated sample (C t10 00 ) significantly decreased by 1.5672.99 l (P ¼ 0.002) but, after adjustment for the reduction in final body weight, it was 0.9574.30 l and no longer statistically significant (P ¼ 0.172). However, the magnitude of the 1-year underestimate of nonequilibrated K t /V using the V determined at baseline (instead of the up-dated V) was the same (À0.07), with a small increase in variability (a standard deviation of 0.16 vs 0.11). Moreover, the difference between baseline sp K t /V and eq K t /V was 0.2370.09 and, as expected, did not change during the follow-up (P ¼ 0.670).
Predictors of the reduction in urea distribution volume
Multiple linear regression using a backward selection strategy showed that the only predictors related to the change in non-eq V after 1 year (Table 3) were baseline albumin levels (P ¼ 0.032) and baseline V values (P ¼ 0.004): low baseline albumin and high baseline V levels were associated with a greater reduction in V over time. This simple two-predictor model has a consistent predictive power (adjusted R 2 ¼ 0.40).
When the dependent variable of the model was changed from the change in non-eq V to the change in eq V, the predictors remained the same (data not shown).
Simple linear regression showed a significant inverse correlation between V values and patient age (B coefficient À0.313; R 2 ¼ 0.21; P ¼ 0.003) (Figure 1 ), but this explained only 20% of the total reduction in V after 1-year follow-up. Moreover, there is a weak and not significant direct correlation between serum albumin levels and urea distribution volume at baseline (B coefficient 0.012, R 2 ¼ 0.07; P ¼ 0.105) (Figure 2 ).
DISCUSSION
The relevant information coming from the results of this multicenter study can be summarized as follows: (a) equilibrated and non-equilibrated urea distribution volume decreases over time in clinically hemodialysis stable patients; (b) in depuration terms, the slight underestimate of K t /V during follow-up using baseline V is of the same magnitude using either the equilibrated or non-equilibrated post-dialysis samples; and (c) lower baseline albumin levels are associated with a greater reduction in V over time.
The reduction in V after 1 year without any significant change in body weight is the major and so far unpublished finding. One possible reason for this could be the increasing age of the patients during the follow-up, but the expected reduction in V with age (0.31 l) is insufficient to explain the observed reduction of 1.56 l. It is worth underlining the fact that this considerable reduction in V over time was observed in apparently clinically stable patients and, given the fact that 73% of lean body mass is body water, could have nutritional importance. It can be estimated that our patients lost an average of 2.1 kg of lean body mass (1.56 l divided by 0.73), with an apparent loss of only 0.6 kg of total body mass.
The dietary advice given to our patients was to eat 1.2 g/ kg/day of proteins, and at least 35 kcal/kg/day. However, the baseline protein catabolic rate was not a predictor of the reduction in V during the follow-up, probably because it depends not only on dietary protein intake but also on net protein catabolism. This suggests that there may be a need for more complete nutritional surveillance even in apparently stable dialysis patients. Body weight is a result of the two components of fat-free and fat mass: the first is obviously related to urea distribution, but a reduction in V can be associated with a constant body weight if there is a concomitant increase in fat mass. Unfortunately, we did not measure fat mass, but we can postulate a greater increase than that physiologically observed in the elderly.
A true reduction in urea distribution volume over time can therefore be interpreted as a clinically unfavorable condition but, although this may be true for the dialysis population as a whole, it is less reliable on an individual patient basis because of the high intra-patient variability in the kinetic calculation of V. In a study of 50 stable hemodialysis patients, Kloppenburg et al. 13 found that it needs at least two or six V measurements to have a 95% probability that the average of the observed values is, respectively, within 20 and 10% error. Being aware of that, and in an attempt to control this phenome non satisfactorily, we made three kinetic evaluations of V in 1 week and then averaged the three values for analysis. We also found considerable variability in the reduction in urea distribution volume after 1 year of follow-up, as shown by the high standard deviation values.
The American and European guidelines, 9,10 suggest determining K t /V monthly, thus making it necessary to determine pre and post-dialysis urea concentration each month in order to calculate V and K t /V according to the single-pool kinetic model. However, provided that V is calculated accurately and its value does not change in stable patients, ID provides an adequate estimate of dialyzer urea clearance corrected for recirculation and can therefore be used to calculate K t /V at each dialysis session without the need for blood samples or laboratory determinations. On the basis of our results, given its variability, the practice of evaluating V once a month may not be satisfactory, and so a good compromise could be to determine it less frequently but repeatedly (e.g. three times every 6 months).
Using the single-pool, urea kinetic model and ID as dialyzer urea clearance, we obtained higher eq V values than non-eq V values: an absolute increase of 8% (from 47 to 55% of end-dialysis body weight), and a relative increase of 17%. This is expected because, in the urea kinetic model, the value of V directly correlates with urea clearance, and inversely with the magnitude of the dialysis decrease in plasma urea concentrations. 22 Given urea rebound, 6 C t30 0 was higher than C t10 00 , and the magnitude of the decrease in plasma urea concentrations using C t30 0 was less than that using C t10 00 , with a consequently greater value in eq V than in non-eq V. What is important is that both eq V and non-eq V showed similar variations over time in both absolute and relative terms, thus suggesting that the change in V over time is methodindependent. However, assuming constant V values, the reduction in V after 1 year had the average consequence of a 5% underestimate of true K t /V (an absolute difference of 0.07 in both eq K t /V and sp K t /V). As this is an underestimate and not an overestimate, we can avoid the risk of under-dialysis when the dialysis dose is estimated using baseline V values.
The reduction in ID after 1 year of follow-up was unexpected, and could have been due to a decrease in the blood water flow/blood flow ratio secondary to an increase in hematocrit or total protein concentrations, or decreased dialyzer efficiency. It must also be remembered that ID is influenced by recirculation, and so a further explanation could be an increase in total recirculation. Unfortunately, we cannot verify these hypotheses because hematocrit values were only recorded at baseline, and recirculation was not determined. Finally, we can assume that a reduction in V reduces ionic flux (and thus ID) as a result of small changes in sodium plasma water during ID measurements. 21 Finally, our results concerning the explored predictors of a reduction in V over time underline the predictive role of albumin levels not only in terms of morbidity and mortality, 22 but also in nutritional terms because high albumin levels are associated with the better preservation of baseline V over time and corroborate the hypothesis of urea distribution volume as a nutritional index. On the other hand, the inverse relationship between the change in V over time and the baseline V values may be due to sub-clinical overhydration at baseline and the effect of a regression to the mean, although the three baseline evaluations of V should have reduced the magnitude of this statistical phenomenon. Finally, in our patients, albumin levels and total body water values are not significantly related. At this regard, Dumler 23 reported similar results when considering total body water and a significant inverse relationship when considering extracellular water content.
In conclusion, in terms of depuration, the underestimate of K t /V during follow-up using baseline V values suggests that a kinetic V evaluation every year may be sufficient as the risk of underestimating the dialysis dose can only lead to an increase in the delivered dose. However, the considerable reduction in V over time in apparently clinically stable patients could be a nutritional index, and may suggest that, at least in patients with low albumin levels, V should be more frequently evaluated in order to detect a possible indolent loss of lean body mass.
MATERIALS AND METHODS
Between February 1999 and April 2000, 52 clinically stable patients on thrice-weekly bicarbonate dialysis were recruited in 13 Italian dialysis centers. The entry criteria were an age of 18-80 years, bicarbonate hemodialysis three times a week for at least 6 months using two needles and a dialyzer of any type, and written consent to participate. The exclusion criteria were residual renal function 41 ml/min/1.73 m 2 or diuresis 4200 ml/day, single-needle hemodialysis and an unstable clinical condition in the 3 months preceding enrolment (e.g. myocardial infarction, vascular access thrombosis, transient ischemic attack, clinically relevant infection including sepsis).
It was planned that each patient would undergo a 1-year followup. The enrolled patients were dialyzed using an Integra machine equipped with the Diascan Module (Gambro-Dasco, Medolla, Italy), which is capable of giving repeated measurements of ID during a dialysis session. The first measurement was completed 10 min after the start of the session, and the subsequent measurements were made every 30 min. V was assessed during three consecutive dialysis sessions at baseline and after 1 year using the single-pool, variable volume urea kinetics model 24 and the mean value of repeated instantaneous determinations of ID. All of the input parameters necessary to calculate V were determined at each session for 1 week. The blood samples for plasma urea concentration analysis were taken before the start (C 0 ), at the end of the session with the blood speed pump reduced a 100 ml/min for 10 s (C t10 00 ), and 30 min after the end of the session (C t30 0 ); C t10 00 and C t30 0 were, respectively, used to determine the non-equilibrated ( non-eq V) and equilibrated urea distribution V ( eq V). The mean baseline values were used as reference. Single-pool K t /V ( sp K t /V) and equilibrated K t /V ( eq K t /V) were also calculated.
The dialysis schedule (dialysis modality, dialyzer membrane, filter surface, dialysate composition) during the study was left unchanged from that used in the period before enrolment.
Sample size calculation
The sample size was calculated considering the difference in baseline/1-year K t /V as the main response variable: a variation of 10% with a standard deviation of 15%. The calculated sample size of 50 patients was based on a significance level (a error) of 0.05, a b error of 0.05, a power (1Àb) of 0.95, a two-tailed paired t-test, and a drop-out rate of 30%.
Statistical analysis
The descriptive analysis of the patients at baseline was based on the mean values and standard deviations of normally distributed continuous variables; the median values and inter-quartile ranges of skewed continuous variables; and the counts and percentages of categorical variables.
The changes in body weight, ID, V, K t /V, the urea reduction ratio, and the protein catabolic rate after 1 year were investigated using the paired-sample t-test. A multiple linear regression model without intercept was used to explore which of the following covariates and factors significantly related (Po0.05) to the change in V after 1 year: age, gender, dialysis vintage, dialysis treatment time, baseline values of V, urea reduction ratio, protein catabolic rate, hematocrit, C reactive protein and albumin. Baseline V was included in the model in order to take into account the possible regression to the mean due to random error in the evaluation of the true V value at baseline in some patients. R 2 was calculated in order to measure how much of the variability on the y-axis (change in V) was explained by the variation in the predictors. The backward approach was used, and a probability value of less than 0.05 was considered statistically significant.
The V values at baseline were plotted against the age of the patients in order to explore how much of a reduction can be expected after 1 year in relation to increased age.
All of the analyses were made using SPSS statistical software for Windows, release 11.
Informed consent and ethical surveillance Before starting the study, the patients were informed about its aims, the expected benefits to them and/or others, the risks and inconveniences involved, and their right to refuse to participate or to withdraw from the study at any time without sanction. Their written consent was obtained. The study was carried out in accordance with the Declaration of Helsinki and its subsequent modifications, and was approved by the Ethics Committees of the participating centers.
